*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 10.74 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 055: NERVOUS SYSTEM NEOPLASMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 43,598 | ||||
| Total Hospitalizations with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 490 | ||||
| DRG Share of Total Hospitalizations | 0.13 | ||||
| % of Total ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease in DRG | 25.36 | ||||
| Avg LOS at DRG | 5.58 | ||||
| Avg LOS with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 7.06 | ||||
| Readmission Rate at DRG | 27.89 | ||||
| Readmission Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 19.36 | ||||
| Unplanned Readmission Rate at DRG | 14.61 | ||||
| Unplanned Readmission Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 11.85 | ||||
| Total Medicare payments at DRG | $420,580,748 | ||||
| Total Medicare payments with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $4,823,999 | ||||
| Total Medicare payment per Day at DRG | $1,728 | ||||
| Total Medicare payment per Day with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $1,394 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,647 | ||||
| Total Medicare payment per Hospitalization with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $9,845 | ||||
| Total Medicare Charges at DRG | $2,165,508,049 | ||||
| Total Medicare Charges with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $25,764,165 | ||||
| Avg Charges at DRG | $49,670 | ||||
| Avg Charges with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $52,580 | ||||
| Mortality Rate at DRG | 4.23 | ||||
| Mortality Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 6.53 | ||||
| SNF Discharge Rate at DRG | 18.01 | ||||
| SNF Discharge Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 20.82 | ||||
| Home Discharge Rate at DRG | 29.57 | ||||
| Home Discharge Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 13.88 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 542: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 843: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 57,175 | ||||
| Total Hospitalizations with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 57 | ||||
| DRG Share of Total Hospitalizations | 0.17 | ||||
| % of Total ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease in DRG | 2.95 | ||||
| Avg LOS at DRG | 6.45 | ||||
| Avg LOS with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 7.95 | ||||
| Readmission Rate at DRG | 26.69 | ||||
| Readmission Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Unplanned Readmission Rate at DRG | 20.8 | ||||
| Unplanned Readmission Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Total Medicare payments at DRG | $651,389,136 | ||||
| Total Medicare payments with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $677,637 | ||||
| Total Medicare payment per Day at DRG | $1,767 | ||||
| Total Medicare payment per Day with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $1,496 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,393 | ||||
| Total Medicare payment per Hospitalization with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $11,888 | ||||
| Total Medicare Charges at DRG | $3,285,887,644 | ||||
| Total Medicare Charges with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $3,789,231 | ||||
| Avg Charges at DRG | $57,471 | ||||
| Avg Charges with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $66,478 | ||||
| Mortality Rate at DRG | 12.27 | ||||
| Mortality Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 22.81 | ||||
| SNF Discharge Rate at DRG | 12.94 | ||||
| SNF Discharge Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Home Discharge Rate at DRG | 28.03 | ||||
| Home Discharge Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 436: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 040: PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 25,894 | ||||
| Total Hospitalizations with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 21 | ||||
| DRG Share of Total Hospitalizations | 0.08 | ||||
| % of Total ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease in DRG | 1.09 | ||||
| Avg LOS at DRG | 4.56 | ||||
| Avg LOS with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 5.67 | ||||
| Readmission Rate at DRG | 28.1 | ||||
| Readmission Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Unplanned Readmission Rate at DRG | 20.72 | ||||
| Unplanned Readmission Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Total Medicare payments at DRG | $195,828,532 | ||||
| Total Medicare payments with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $143,050 | ||||
| Total Medicare payment per Day at DRG | $1,657 | ||||
| Total Medicare payment per Day with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $1,202 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,563 | ||||
| Total Medicare payment per Hospitalization with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $6,812 | ||||
| Total Medicare Charges at DRG | $1,026,791,842 | ||||
| Total Medicare Charges with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $780,037 | ||||
| Avg Charges at DRG | $39,654 | ||||
| Avg Charges with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $37,145 | ||||
| Mortality Rate at DRG | 5.45 | ||||
| Mortality Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| SNF Discharge Rate at DRG | 9.23 | ||||
| SNF Discharge Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Home Discharge Rate at DRG | 45.39 | ||||
| Home Discharge Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 231,812 | ||||
| Total Hospitalizations with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 16 | ||||
| DRG Share of Total Hospitalizations | 0.71 | ||||
| % of Total ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease in DRG | 0.83 | ||||
| Avg LOS at DRG | 4.41 | ||||
| Avg LOS with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | 7.88 | ||||
| Readmission Rate at DRG | 29.12 | ||||
| Readmission Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Unplanned Readmission Rate at DRG | 22.82 | ||||
| Unplanned Readmission Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Total Medicare payments at DRG | $1,743,376,418 | ||||
| Total Medicare payments with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $159,486 | ||||
| Total Medicare payment per Day at DRG | $1,704 | ||||
| Total Medicare payment per Day with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $1,266 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,521 | ||||
| Total Medicare payment per Hospitalization with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $9,968 | ||||
| Total Medicare Charges at DRG | $8,543,867,896 | ||||
| Total Medicare Charges with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $721,128 | ||||
| Avg Charges at DRG | $36,857 | ||||
| Avg Charges with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | $45,071 | ||||
| Mortality Rate at DRG | 2.89 | ||||
| Mortality Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| SNF Discharge Rate at DRG | 22.92 | ||||
| SNF Discharge Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA | ||||
| Home Discharge Rate at DRG | 43.02 | ||||
| Home Discharge Rate with ICD G131 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 25 |
| ARTHUR G JAMES CANCER HOSPITAL | 300 W 10TH AVE | COLUMBUS | OH | 43210 | 23 |
| FROEDTERT MEMORIAL LUTHERAN HOSPITAL | 9200 W WISCONSIN AVE | MILWAUKEE | WI | 53226 | 23 |